Risk factors for survival and local recurrence after particle radiotherapy for single small hepatocellular carcinoma

British Journal of Surgery

Volumn 98, Issue 4, 2011, Pages 558-564

  Komatsu, S ^a,b   Murakami, M ^b   Fukumoto, T ^a   Hori, Y ^a   Hishikawa, Y ^b   Ku, Y ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Hyogo Ion Beam Medical Centre   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; EVALUATION; FEMALE; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; RADIOTHERAPY; RISK FACTOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RADIOTHERAPY; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79952005824     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7397     Document Type: Article

References (27)

1. El-Serag HB, Rudolph KL,. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576. (Pubitemid 46890874)
2. Llovet JM, Bruix J, Gores GJ,. Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy. Hepatology 2000; 31: 1019-1021. (Pubitemid 30169952)
3. Harrison LE, Koneru B, Baramipour P, Fisher A, Barone A, Wilson D, et al., Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg 2003; 197: 759-764. (Pubitemid 38199577)
4. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L,. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005; 242: 158-171. (Pubitemid 41033431)
5. Berber E, Siperstein A,. Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors. Ann Surg Oncol 2008; 15: 2757-2764.
6. Tse RV, Guha C, Dawson LA,. Conformal radiotherapy for hepatocellular carcinoma. Crit Rev Oncol Hematol 2008; 67: 113-123. (Pubitemid 351893107)
7. Cheng JC, Wu JK, Huang CM, Liu HS, Huang DY, Tsai SY, et al., Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease. Int J Radiat Oncol Biol Phys 2003; 56: 229-234. (Pubitemid 36403696)
8. Mornex F, Girard N, Beziat C, Kubas A, Khodri M, Trepo C, et al., Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapiesa mature results of the French Phase II RTF-1 trial. Int J Radiat Oncol Biol Phys 2006; 66: 1152-1158. (Pubitemid 44740208)
9. Chiba T, Tokuuye K, Matsuzaki Y, Sugahara S, Chuganji Y, Kagei K, et al., Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Clin Cancer Res 2005; 11: 3799-3805. (Pubitemid 40685599)
10. Bush DA, Hillebrand DJ, Slater JM, Slater JD,. High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial. Gastroenterology 2004; 127 (Suppl 1): S189-S193. (Pubitemid 39423387)
11. Kato H, Tsujii H, Miyamoto T, Mizoe JE, Kamada T, Tsuji H, et al., Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int J Radiat Oncol Biol Phys 2004; 59: 1468-1476. (Pubitemid 38954070)
12. Kawashima M, Furuse J, Nishio T, Konishi M, Ishii H, Kinoshita T, et al., Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma. J Clin Oncol 2005; 23: 1839-1846. (Pubitemid 46211361)
13. Suit H, DeLaney T, Goldberg S, Paganetti H, Clasie B, Gerweck L, et al., Proton vs carbon ion beams in the definitive radiation treatment of cancer patients. Radiother Oncol 2010; 95: 3-22.
14. Liver Cancer Study Group of Japan. General Rules for the Clinical and Pathological Study of Primary Liver Cancer (2nd English edn). Kanehara: Tokyo, 2003.
15. Nakashima Y, Nakashima O, Tanaka M, Okuda K, Nakashima M, Kojiro M,. Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res 2003; 26: 142-147. (Pubitemid 36927185)
16. Demizu Y, Murakami M, Miyawaki D, Niwa Y, Akagi T, Sasaki R, et al., Analysis of vision loss caused by radiation-induced optic neuropathy after particle therapy for head-and-neck and skull-base tumors adjacent to optic nerves. Int J Radiat Oncol Biol Phys 2009; 75: 1487-1492.
17. Iwata H, Murakami M, Demizu Y, Miyawaki D, Terashima K, Niwa Y, et al., High-dose proton therapy and carbon-ion therapy for stage I nonsmall cell lung cancer. Cancer 2010; 116: 2476-2485.
18. National Cancer Institute. National Cancer Institute Cancer Therapy Evaluation Program: Common Terminology Criteria for Adverse Events, version 2.0. National Cancer Institute: Bethesda, 1998.
19. Hu RH, Lee PH, Chang YC, Ho MC, Yu SC,. Treatment of centrally located hepatocellular carcinoma with central hepatectomy. Surgery 2003; 133: 251-256.
20. Komatsu S, Hori Y, Fukumoto T, Murakami M, Hishikawa Y, Ku Y,. Surgical spacer placement and proton radiotherapy for unresectable hepatocellular carcinoma. World J Gastroenterol 2010; 16: 1800-1803.
21. Fukumoto T, Komatsu S, Hori Y, Murakami M, Hishikawa Y, Ku Y,. Particle beam radiotherapy with a surgical spacer placement for advanced abdominal leiomyosarcoma results in a significant clinical benefit. J Surg Oncol 2010; 101: 97-99.
22. Lam VW, Ng KK, Chok KS, Cheung TT, Yuen J, Tung H, et al., Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: analysis of risk factors and prognostic factors. Ann Surg Oncol 2008; 15: 782-790.
23. Chen MH, Yang W, Yan K, Hou YB, Dai Y, Gao W, et al., Radiofrequency ablation of problematically located hepatocellular carcinoma: tailored approach. Abdom Imaging 2008; 33: 428-436. (Pubitemid 351713079)
24. Lu DS, Raman SS, Limanond P, Aziz D, Economou J, Busuttil R, et al., Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 2003; 14: 1267-1274. (Pubitemid 37266660)
25. Mizumoto M, Tokuuye K, Sugahara S, Nakayama H, Fukumitsu N, Ohara K, et al., Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis. Int J Radiat Oncol Biol Phys 2008; 71: 462-467.
26. Choi GH, Han DH, Kim DH, Choi SB, Kang CM, Kim KS, et al., Outcome after curative resection for a huge (>or = 10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification. Am J Surg 2009; 198: 693-701.
27. Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, et al., Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002; 20: 1527-1536. (Pubitemid 34260532)